News
News

The latest updates from AFAR.

Board Members in the News: Wall Street Journal features Nir Barzilai and James Kirkland  on Biomarkers and Rates of Aging

Jul 13
2015

Board Members in the News: Wall Street Journal features Nir Barzilai and James Kirkland on Biomarkers and Rates of Aging View MoreBACK

On July 13th, the Wall Street Journal featured Deputy Scientific Director Dr. Nir Barzilai and Board Member Dr. James Kirkland an article exploring new research into difference between the rates of biological aging among those with the same chornological age.  Our experts discussed how increased research into the biomarkers of aging may improve care in the future.

Researchers found that by tracking a set of 18 biomarkers among a group of chronologically 26 to 38 years over 10 years, biological age at the end of the study ranged from 28 to 61.  Dr. Barzilai states that a deeper understanding of biological age may help cut health cost because physicians will be able to delay the use certain tests and procedures among those who are biologically young.  However, Dr. Kirkland reminded that, due to the risk of unknown side effects, this research may not result in earlier treatments.  

Nir Barzilai, MD, is the Director of the Institute for Aging Research at Albert Einstein College of Medicine and a two-time AFAR grant recipient.

James Kirkland, MD, PhD, is the director of the Robert and Arlene Kogod Center on Aging at the Mayo Clinic and the 2012 recipient of a Glenn/AFAR Breakthroughs in Gerontology Award.

For more information on the Biomarkers of Aging, download our InfoAging factsheet here.





View MoreBACK TO TOP